FDA Grants SeaStar Medical Two New Breakthrough Device Designations for SCD Therapy to Treat Systemic Inflammatory Response in Adult and Pediatric Patients Undergoing Cardiac Surgery

  • Kevin Chung

Press/Media

Period9 Apr 2025

Media coverage

1

Media coverage

  • TitleFDA Grants SeaStar Medical Two New Breakthrough Device Designations for SCD Therapy to Treat Systemic Inflammatory Response in Adult and Pediatric Patients Undergoing Cardiac Surgery
    Media name/outletBioSpace
    Country/TerritoryUnited States
    Date9/04/25
    URLct.moreover.com/?a=56449859557&p=1gw&v=1&x=PVaTFFkXxfuD-auCKPaDWQ
    PersonsKevin Chung
View all 1
View less